Physician profile
Roger B Cole
NPI 1235399882
$919.49
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $337 · 2020: $428 · 2021: $155.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $211.93 | 2019-2021 | |
| Novo Nordisk INC | $119.69 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $96.83 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $75.90 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $61.04 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $52.86 | 2019-2021 | |
| Astellas Pharma US INC | $52.22 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.95 | 2020 | |
| Eisai INC. | $44.64 | 2020-2021 | |
| Allergan, INC. | $41.60 | 2020 | |
| Pfizer INC. | $36.45 | 2019 | |
| Amarin Pharma, INC. | $35.28 | 2019-2020 | |
| Abbvie INC. | $13.98 | 2021 | |
| Kaleo, INC. | $11.79 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.21 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $8.12 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.